Eptifibatide (AuroMedics Pharma LLC)
Welcome to the PulseAid listing for the Eptifibatide drug offered from AuroMedics Pharma LLC. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AuroMedics Pharma LLC |
NON-PROPRIETARY NAME: | Eptifibatide |
SUBSTANCE NAME: | EPTIFIBATIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-12-08 |
END MARKETING DATE: | 0000-00-00 |
Eptifibatide HUMAN PRESCRIPTION DRUG Details:
Item Description | Eptifibatide from AuroMedics Pharma LLC |
LABELER NAME: | AuroMedics Pharma LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/100mL) |
START MARKETING DATE: | 2015-12-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55150-218_af432eeb-dd03-4b5d-b57d-85b9abe09705 |
PRODUCT NDC: | 55150-218 |
APPLICATION NUMBER: | ANDA206127 |
Other EPTIFIBATIDE Pharmaceutical Manufacturers / Labelers: